Bio Solution Co.,Ltd. Logo

Bio Solution Co.,Ltd.

Develops cell therapies for degenerative diseases and supplies bio-lab reagents for R&D.

086820 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
서울특별시 노원구 공릉로 232 5층 (공릉동, 서울테크노파크), 서울특별시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Based on the provided sources, Bio Solution Co., Ltd. is a biotechnology and life sciences company, not a financial data provider. The company develops, manufactures, and sells cell therapy products for degenerative diseases. Its offerings include CartiLife, an autologous chondrocyte cell-based therapy. Additionally, the company produces and supplies a range of bio-laboratory reagents and kits for research and development purposes. These products are used in applications such as yeast two-hybrid assays, nucleic acid precipitation, and protein and DNA electrophoresis. The company is ISO 13485:2016 certified, indicating adherence to quality management standards for medical devices.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Bio Solution Co.,Ltd. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-09-17 00:00
Regulatory News Service
투자판단관련주요경영사항(임상시험계획승인신청) (펠렛형 동종 연골세포치료제(카티로이드)의 호주 제1/2상 임상시험계획 승…
Korean 8.9 KB
2025-08-25 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 6.8 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.5 MB

Automate Your Workflow. Get a real-time feed of all Bio Solution Co.,Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Bio Solution Co.,Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Novartis AG Logo
Develops and markets innovative medicines globally using advanced science and technology.
Switzerland NOVN
Develops first-in-class drugs and supplements for metabolic and fibrotic diseases.
South Korea 229500
Novo Nordisk Logo
Develops medicines and devices for chronic diseases like diabetes, obesity, and rare disorders.
Denmark NOVO
NUFORMIX PLC Logo
Repurposing drugs for fibrosis and oncology using proprietary cocrystal technology.
United Kingdom NFX
NUTEX Investments Plc Logo
Develops & distributes health, cosmetic & pharma products from natural ingredients globally.
Hungary NUTEX
Nxera Pharma Co., Ltd. Logo
Biopharma using SBDD tech to develop medicines for neurology and gastroenterology.
Japan 4565
ObsEva SA Logo
Developed novel therapeutics for women's reproductive health and pregnancy.
Switzerland OBSN
ODI Pharma AB Logo
Distributes pharmaceutical medicinal cannabis products across Eastern Europe, with a focus on Poland.
Sweden ODI
OliX Pharmaceuticals, Inc. Logo
Developing RNAi therapeutics for dermatology, ophthalmology, and metabolic diseases via an asiRNA platform.
South Korea 226950
ONCODESIGN Logo
Developing precision oncology solutions for resistant and metastatic cancers.
France ALONC

Talk to a Data Expert

Have a question? We'll get back to you promptly.